^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SIBP-02 (rituximab biosimilar)

    i
    Other names: SIBP-02
    Associations

    News

    Trials
    Company:
    Sinopharm
    Drug class:
    CD20 inhibitor
    Related drugs:
    Associations

    News

    Trials
    11ms
    A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL (clinicaltrials.gov)
    P3, N=421, Completed, Shanghai Institute Of Biological Products | Unknown status --> Completed
    Trial completion
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 positive
    |
    doxorubicin hydrochloride • cyclophosphamide • SIBP-02 (rituximab biosimilar)